AAAnastasiya S. Artemova

Anastasiya S. Artemova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anastasiya S. Artemova has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical and Ultrasound Semiotics of Varicose Vein Recurrence

    by E.K. Gavrilov, R.A. Akhadov, A.S. Artemova, E.A. Babinets, G.G. Khubulava

    Objective. To study clinical and ultrasound semiotics of primary varicose vein recurrence after invasive treatment. Material and methods. We analyzed 64 consecutive patients with varicose vein recurrence after invasive treatment (crossectomy, stripping (35 patients) and thermal obliteration (27 patients)). Ehere were 21 men (32.8%) and 43 women (67.2%) (mean age 50.8±1.6). Recurrence variants and their combinations were analyzed. Reflux sources were recorded in accordance with the REVAS classification. We estimated time interval after surgery, period between surgery and recurrence, the number of invasive interventions, localization of recurrent varicose veins, including their relationship with sites of previous interventions, CEAP class. Results. The median period after invasive treatment was 53 months. Recurrence within the area of previous procedure was registered in 14 patients (21.9%), outside these areas — in 11 patients (17.2%). Combined localization was revealed in 39 patients (60.9%). Recurrence due to disease progression was detected in 11 patients (17.2%), residual veins — in 2 patients (3.1%), recurrent veins — in 3 patients (4.7%), combination — in 48 patients (75%). Neovascularization was detected in 11 patients (17.2%). One source of reflux out of seven possible according to the REVAS classification was detected only in 7 patients (10.9%). Other 57 (89.1%) ones had two or more sources. Trunk insufficiency was detected in 53 patients (82.8%). Incompetent segments of the main saphenous veins after open and endovenous procedures were detected in 11 and 24 patients, respectively (35%/54.7%). Insufficiency of veins that were intact before the first procedure was detected in 18 (28.1%) patients. When analyzing the subgroups after high ligation with stripping and thermal ablation, we found significant differences in time after the first procedure, localization of recurrent varicose veins, incidence of trunk incompetence and previous treatment mistakes. Conclusion. The structure of recurrences is similar after high ligation with stripping and thermal obliteration with phlebectomy. Differences in rates of certain recurrence are probably associated with tactical and technical features of two treatment approaches.


  • Open Access

    Experts’ views on recurrence and progression of varicose veins

    by V. Yu. Bogachev, O. A. Alukhanyan, G. N. Vanyan, S. M. Markin, A. S. Artemova, P. F. Kravtsov

    Introduction. Despite modern advances in technologies for the treatment and prevention of varicose veins, there is currently no radical treatment for varicose veins. The probability of recurrence of dilated veins, according to various authors, ranges from 5 to 70%. Along with the well-established concept of recurrence of varicose veins, the term progression of varicose veins is increasingly common in everyday life.Aim. To study the current understanding of the term relapse and the practical attitude of specialists involved in the treatment of varicose veins to it.Material and methods. In 2023, a survey of 117 specialists on the recurrence/progression of varicose veins was conducted. The respondents were doctors involved in the treatment of varicose veins: vascular surgeons 22.4%, phlebologists 50%, general surgeons 19.8%, specialists in ultrasound/functional diagnostics 7.8%, X-ray endovascular surgeon 0.85%. The questionnaire included 18 questions regarding the frequency of visits of patients with relapse/progression of varicose veins; views on tactics, as well as the attitude of specialists to the issue of progression and recurrence of varicose veins in patients after its surgical treatment.Results and discussion. The concept of recurrence and progression of varicose veins among specialists dealing with this pathology is not always comparable. There are differences in views both on the predisposing factors for the recurrence of dilated veins, and, accordingly, on the tactics of treatment and preventive measures. In some cases, according to statistics, they are due to specialization.Conclusions. The incidence of relapse and progression at the reception of the respondents has a slight difference. Despite the fact that there are opinions that do not correspond to generally accepted and abhorrent collegiality, mostly specialists try to separate these concepts, see differences in provoking factors and, accordingly, in recommendations.


  • Endovascular treatment of deep femoral artery lesion in high-risk patients with critical lower limb ischemia

    by A.G. Vanyurkin, N.V. Susanin, Yu.K. Belova, A.S. Artemova, N.S. Odintsov, V.A. Solovev, M.A. Chernyavsky

    OBJECTIVE To analyze in-hospital results of endovascular treatment of severe deep femoral artery lesions combined with extended femoropopliteal occlusion in comorbid patients with critical lower limb ischemia. MATERIAL AND METHODS A single-center non-randomized prospective study included 51 patients aged 71±8 years with deep femoral artery (DFA) lesions and extensive occlusion of superficial femoral artery (SFA), popliteal artery (PA) and tibial arteries between January 2017 and April 2021. Preoperative trophic lesions were registered in 15 (30%) patients, rest pain — in 36 (70%) patients. All ones underwent previous at least one ipsilateral reconstructive intervention. Comorbidity was determined by age and concomitant diseases. According to preoperative CT angiography, all patients had SFA occlusion, 36 (70.5%) patients — occlusion of SFA and PA, 4 (8%) patients — occlusion of SFA, PA and tibioperoneal trunk, 11 (21%) patients — occlusion of SFA, PA, tibioperoneal trunk and one tibial artery. DFA occlusion was detected in 24 (47%) patients, stenosis >70% — in other cases (53%). Mean length of DFA lesion was 37±24 mm. RESULTS All patients underwent endovascular correction of DFA lesions. Patients with trophic ulcers underwent complete endovascular correction of femoropopliteal segment and revascularization of deep femoral artery. Technical success rate was 100%. Early postoperative period was uneventful in 100% of cases. Among patients with ischemia Fontein grade 3 (n=36), pain relief occurred in 35 (97%) ones. Among 11 patients with ischemia grade 4, healing of trophic lesions was noted in 9 (82%) patients. Minor amputation in postoperative period was required in 2 (4%) patients. There were no in-hospital deaths. CONCLUSION Endovascular correction of severe DFA lesions combined with extended occlusion of femoropopliteal segment is an effective and safe alternative to open surgical treatment in patients with critical lower limb ischemia. Clinical outcomes in comorbid patients with previous ipsilateral reconstructive interventions are characterized by acceptable pain relief and healing of trophic changes (97% and 82%, respectively).

  • Lipedema: a professional community's view

    by Anastasiya S. Artemova, Sergey M. Markin, Pavel F. Kravtsov

    BACKGROUND: Lipedema is a chronic disease characterized by abnormal growth of subcutaneous fatty tissue. More than 10% of women have varying degrees of lipedema. Despite the high prevalence of this pathology, to date, there are no full-fledged clinical guidelines, and only sporadic publications have devoted to this disease in the literature. AIM: To determine the level of immersion of members of the professional community in the diagnosis and treatment of lipedema. METHODS: Within the framework of the online educational event “Lipedema: 2023” held on the platform “Actual Phlebology” on 22.08.23, 74 physician participants anonymously answered 14 questions on the diagnosis and treatment of patients with lipedema. RESULTS: In this study, 83.8% of the respondents adhered to the hereditary theory of lipedema development. Only one obvious feature of lipedema, the presence of bilateral symmetrical disproportionate proliferation of adipose tissue on the extremities, was reported by the absolute majority (98.6%) of the specialists interviewed. Less than half of the professional participants noted features such as a feeling of tightness and an excessive tendency to hematoma formation with worsening of symptoms overnight. More than half of the respondents (54.1%) admitted that they were unfamiliar with the classification of lipedema. The main method of conservative treatment of lipedema was considered therapeutic exercise by 74.3% of the respondents. The most popular method of surgical treatment of lipedema is lymphatic liposuction, and which 56.8% of the participants of the professional community are ready to offer this to their patients. CONCLUSION: The professional community is not sufficiently immersed in the diagnosis and treatment of patients with lipedema. The diversity of current scientific evidence on lipedema requires that it be structured in the development of up-to-date national clinical guidelines.

  • Open Access

    Diabetes mellitus and long-time outcomes of autovenous femoro-popliteal bypass

    by A. S. Artemova, M. A. Chernyavskiy

    BACKGROUND: the effect of diabetes mellitus on the long-term patency of autovenous femoro-popliteal bypass has not been definitively determined AIM: to determine the effect of diabetes mellitus on the long-term outcomes of autovenous femoral-popliteal bypass.MATERIALS AND METHODS: the results of treatment of 648 patients who underwent autovenous femoral-popliteal bypass were analyzed. The patients were divided into 2 clinical groups: the first group included 367 patients with diabetes mellitus, the second — 281 patients without the named disease. The groups did not differ significantly in the incidence of concomitant pathology.RESULTS: occlusion of the autovenous conduit within a 5-year period after surgical treatment was observed in 218 patients of the first group (59.4%) and 72 patients of the second group (25.6%) (p 2 = 39.05, RR = 1.78; CI = 1.53–2.12). The average service life of the autovenous femoral-popliteal bypass was 63.49 months in patients of the first group, and 107.46 months in the second. The decompensated course of diabetes mellitus was observed in 203 patients (55.2%). Among patients with decompensated diabetes mellitus, occlusion of the autovenous femoral-popliteal bypass was observed in 95 patients (46.8%), in 104 patients the autovenous conduit was passable (51.2%; p = 0.449, χ2 = 0.57). Decompensated course of diabetes mellitus may contribute to a decrease in the service life of autovenous femoro-popliteal bypass.CONCLUSION: the presence of diabetes mellitus, and especially its decompensated course, can negatively affect the patency of autovenous femoro-popliteal bypass in the long term.


  • Immediate results of deep femoral artery revascularization in patients with critical ischemia of the lower extremities following occlusion of autologous venous femoral-popliteal bypass graft

    by A.S. Artemova, Yu.K. Belova, M.A. Chernyavskiy

    Objective. To evaluate various methods of surgical revascularization of deep femoral artery in patients with occlusion of autologous venous femoral-popliteal bypass grafts. Material and methods. We analyzed treatment outcomes in 34 patients with occlusion of autologous venous femoral-popliteal bypass grafts. Occlusion-free period was 45.3±12.0 months. All patients were divided into 2 groups depending on revascularization technique: 20 patients underwent endarterectomy from common and deep femoral arteries (group 1), 14 patients underwent balloon angioplasty with stenting of deep femoral artery (group 2). There were no significant between-group differences in comorbidities. Results. Surgical site infection occurred in 1 (2.9%) case. Healing of trophic disorders within 30 days after surgical treatment was observed in 7 out of 14 patients (50%). One patient underwent redo surgery. Two patients underwent foot amputation within 12 postoperative months. Conclusion. Deep femoral artery revascularization has positive results in patients with chronic lower limb ischemia following occlusion of autologous venous femoral-popliteal bypass grafts. However, blood supply to the lower extremity through the deep femoral artery may be insufficient for healing of trophic ulcers.

  • Results of redo endovascular surgery in patients with occlusion of autovenous femoropopliteal bypass grafts

    by A.S. Artemova, N.V. Susanin, A.G. Vanyurkin, M.A. Chernyavsky

    Objective. To compare the results of endovascular interventions in patients with chronic lower limb ischemia following occlusion of autovenous femoropopliteal bypass grafts. Material and methods. There were 86 patients divided into 3 clinical groups in accordance with repeated arterial reconstruction: 62 patients underwent revascularization, balloon angioplasty with stenting of superficial femoral artery (group 1); 14 patients underwent balloon angioplasty with deep femoral artery stenting (group 2); 10 patients underwent revascularization, balloon angioplasty with stenting of autovenous femoropopliteal bypass graft (group 3). All groups did not differ in age and gender of patients. Results. Mean time of endovascular intervention was 65±16 min. At the first year after surgery, thrombosis of reconstruction area occurred in 11 (12.8%) patients, and false aneurysms after arterial puncture arose in 7 (8.1%) cases (inguinal access — 4 cases, popliteal artery puncture — 3 cases). One (1.2%) patient required amputation due to irreversible ischemia. Conclusion. Endovascular treatment of patients with occlusion of autovenous femoropopliteal bypass grafts is characterized by favorable immediate results.


  • Open Access

    What should a general practitioner know about the management of patients with venous thromboembolism?

    by S. M. Markin, S. V. Grishin, A. S. Artemova

    The era of the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) virus has shown that non-core specialists can be involved in the treatment of epidemic diseases. However, the entire burden for the prevention and treatment of venous thromboembolism (VTE) falls on doctors – cardiovascular surgeons, phlebologists. It should be borne in mind that most of the thromboses – more than 2 million cases per year – are asymptomatic, and only a small part has pulmonary embolism, pulmonary hypertension, and death. The survival rate of patients with deep vein thrombosis (DVT) for 8 years is 65 %, with a combination of DVT with pulmonary embolism; the survival rate does not exceed 34 %, so a doctor of any specialty should know how to suspect VTE. The clinical picture of DVT is not always pronounced. Most often, with DVT, patients complain of swelling and pain in the affected lower limb, a decrease in the volume of active movements, and skin cyanosis. Diagnosis of DVT and thromboembolic complications at the non-specialized level should initially consist of assessing the risk of VTE using special scales, among which the Wales scale is of the greatest importance. The gold standard for diagnosing DVT is duplex ultrasound. Among the main indicators for hospitalization is not the fact of the established diagnosis of DVT, but the presence of comorbid pathology, chronic lung diseases, and old age. Additional risk factors include extended DVT, suspected pulmonary embolism, and pregnancy. The goal of anticoagulant therapy is to stop the process of pathological hypercoagulability, the progression of thrombus formation and create conditions for restoring vascular patency, while the pathological idea is that anticoagulants “dissolve the thrombus”. In this regard, anticoagulant therapy is the mainstay of treatment for DVT. To determine the duration of anticoagulant therapy, the etiology of thrombosis is of particular importance – the trigger that led to the formation of thrombotic masses.


  • Open Access

    Changing attitudes towards compression treatment in real phlebology practice from 2012 to 2022

    by Samara State Medical University of the Ministry of Healthcare of the Russian Federation, P.F. Kravtsov, S.M. Markin, St. Petersburg Clinical Hospital of the Russian Academy of Sciences, A.S. Artemova, St. Petersburg Limited Liability Company “Clinic Altermed”, G.N. Vanyan

    Изменение отношения к компрессионному лечению в реальной флебологической практике с 2012 по 2022 г.